Monoclonal Mouse Antibody Market, Global Outlook and Forecast 2023-2029

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called �antigens�). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C�sar Milstein and Georges K�hler � scientists at the Roche-funded Basel Institute for Immunology � who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Mouse Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Mouse Antibody. This report contains market size and forecasts of Monoclonal Mouse Antibody in global, including the following market information:
Global Monoclonal Mouse Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Monoclonal Mouse Antibody Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Monoclonal Mouse Antibody companies in 2022 (%)
The global Monoclonal Mouse Antibody market was valued at US$ 9246.8 million in 2022 and is projected to reach US$ 12260 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoclonal Mouse Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal Mouse Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Monoclonal Mouse Antibody Market Segment Percentages, by Type, 2022 (%)
    IgM
    IgG
    IgA
    Others
Global Monoclonal Mouse Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Monoclonal Mouse Antibody Market Segment Percentages, by Application, 2022 (%)
    Therapeutic
    Research
    Diagnostic
    ELISA kits
Global Monoclonal Mouse Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Monoclonal Mouse Antibody Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal Mouse Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Monoclonal Mouse Antibody revenues share in global market, 2022 (%)
Key companies Monoclonal Mouse Antibody sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Monoclonal Mouse Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Roche
    Johnson & Johnson
    Merck
    Novartis
    AbbVie
    Amgen
    Pfizer
    Bayer
    Lilly
    Bristol-Myers Squibb
    GlaxoSmithKline
    Biogen
    AstraZeneca
    Sanofi
    Alexion Pharmaceuticals
    Seattle Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monoclonal Mouse Antibody, market overview.
Chapter 2: Global Monoclonal Mouse Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monoclonal Mouse Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Monoclonal Mouse Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.